{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T17:31:07Z","timestamp":1776360667401,"version":"3.51.2"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T00:00:00Z","timestamp":1481155200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00198-016-3861-7","type":"journal-article","created":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T01:32:04Z","timestamp":1481160724000},"page":"1481-1490","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Efficacy and safety of osteoporosis medications in a rat model of late-stage chronic kidney disease accompanied by secondary hyperparathyroidism and hyperphosphatemia"],"prefix":"10.1007","volume":"28","author":[{"given":"M.","family":"Ota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Takahata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Kanehira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kimura-Suda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Kameda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hiratsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,8]]},"reference":[{"key":"3861_CR1","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1755.2000.00178.x","volume":"58","author":"AM Alem","year":"2000","unstructured":"Alem AM, Sherrard DJ, Gillen DL, Weiss NS, Beresford SA, Heckbert SR, Wong C, Stehman-Breen C (2000) Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 58:396\u2013399","journal-title":"Kidney Int"},{"key":"3861_CR2","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1681\/ASN.2005111194","volume":"17","author":"TL Nickolas","year":"2006","unstructured":"Nickolas TL, McMahon DJ, Shane E (2006) Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol: JASN 17:3223\u20133232","journal-title":"J Am Soc Nephrol: JASN"},{"key":"3861_CR3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0140-6736(93)92555-8","volume":"341","author":"SR Cummings","year":"1993","unstructured":"Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, Genant HK, Palermo L, Scott J, Vogt TM (1993) Bone density at various sites for prediction of hip fractures. The study of osteoporotic fractures research group. Lancet 341:72\u201375","journal-title":"Lancet"},{"key":"3861_CR4","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/ki.2013.547","volume":"86","author":"KL Naylor","year":"2014","unstructured":"Naylor KL, McArthur E, Leslie WD et al (2014) The three-year incidence of fracture in chronic kidney disease. Kidney Int 86:810\u2013818","journal-title":"Kidney Int"},{"key":"3861_CR5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1359\/jbmr.060105","volume":"21","author":"SA Jamal","year":"2006","unstructured":"Jamal SA, Gilbert J, Gordon C, Bauer DC (2006) Cortical pQCT measures are associated with fractures in dialysis patients. J Bone Miner Res: Off J Am Soc Bone Miner Res 21:543\u2013548","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"3861_CR6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archinte.167.2.133","volume":"167","author":"KE Ensrud","year":"2007","unstructured":"Ensrud KE, Lui LY, Taylor BC, Ishani A, Shlipak MG, Stone KL, Cauley JA, Jamal SA, Antoniucci DM, Cummings SR (2007) Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med 167:133\u2013139","journal-title":"Arch Intern Med"},{"key":"3861_CR7","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ki.2008.264","volume":"74","author":"TL Nickolas","year":"2008","unstructured":"Nickolas TL, Leonard MB, Shane E (2008) Chronic kidney disease and bone fracture: a growing concern. Kidney Int 74:721\u2013731","journal-title":"Kidney Int"},{"key":"3861_CR8","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 69:1945\u20131953","journal-title":"Kidney Int"},{"key":"3861_CR9","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1359\/jbmr.2003.18.11.1932","volume":"18","author":"Y Jiang","year":"2003","unstructured":"Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF (2003) Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res: Off J Am Soc Bone Miner Res 18:1932\u20131941","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"3861_CR10","first-page":"F706","volume":"266","author":"H Koyama","year":"1994","unstructured":"Koyama H, Nishizawa Y, Inaba M, Hino M, Prahl JM, DeLuca HF, Morii H (1994) Impaired homologous upregulation of vitamin D receptor in rats with chronic renal failure. Am J Phys 266:F706\u2013F712","journal-title":"Am J Phys"},{"key":"3861_CR11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/jbmr.5650060405","volume":"6","author":"JG Seedor","year":"1991","unstructured":"Seedor JG, Quartuccio HA, Thompson DD (1991) The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats. J Bone Miner Res: Off J Am Soc Bone Miner Res 6:339\u2013346","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"3861_CR12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00223-013-9755-1","volume":"93","author":"J Xu","year":"2013","unstructured":"Xu J, Rong H, Ji H, Wang D, Wang J, Zhang W, Zhang Y (2013) Effects of different dosages of parathyroid hormone-related protein 1-34 on the bone metabolism of the ovariectomized rat model of osteoporosis. Calcif Tissue Int 93:276\u2013287","journal-title":"Calcif Tissue Int"},{"key":"3861_CR13","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.bone.2005.02.002","volume":"36","author":"S Komatsubara","year":"2005","unstructured":"Komatsubara S, Mori S, Mashiba T, Nonaka K, Seki A, Akiyama T, Miyamoto K, Cao Y, Manabe T, Norimatsu H (2005) Human parathyroid hormone (1-34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora. Bone 36:678\u2013687","journal-title":"Bone"},{"key":"3861_CR14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bone.2014.04.005","volume":"64","author":"T Shimizu","year":"2014","unstructured":"Shimizu T, Takahata M, Kameda Y, Hamano H, Ito T, Kimura-Suda H, Todoh M, Tadano S, Iwasaki N (2014) Vitamin K-dependent carboxylation of osteocalcin affects the efficacy of teriparatide (PTH(1-34)) for skeletal repair. Bone 64:95\u2013101","journal-title":"Bone"},{"key":"3861_CR15","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","volume":"25","author":"ML Bouxsein","year":"2010","unstructured":"Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R (2010) Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res: Off J Am Soc Bone Miner Res 25:1468\u20131486","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"3861_CR16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR histomorphometry nomenclature committee. J Bone Miner Res: Off J Am Soc Bone Miner Res 28:2\u201317","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"3861_CR17","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.biomaterials.2006.11.043","volume":"28","author":"A Boskey","year":"2007","unstructured":"Boskey A, Pleshko Camacho N (2007) FT-IR imaging of native and tissue-engineered bone and cartilage. Biomaterials 28:2465\u20132478","journal-title":"Biomaterials"},{"key":"3861_CR18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ki.1991.2","volume":"39","author":"J Green","year":"1991","unstructured":"Green J, Kleeman CR (1991) Role of bone in regulation of systemic acid-base balance. Kidney Int 39:9\u201326","journal-title":"Kidney Int"},{"key":"3861_CR19","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.bone.2006.06.002","volume":"39","author":"JS Yerramshetty","year":"2006","unstructured":"Yerramshetty JS, Lind C, Akkus O (2006) The compositional and physicochemical homogeneity of male femoral cortex increases after the sixth decade. Bone 39:1236\u20131243","journal-title":"Bone"},{"key":"3861_CR20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.semnephrol.2009.01.007","volume":"29","author":"PD Miller","year":"2009","unstructured":"Miller PD (2009) Diagnosis and treatment of osteoporosis in chronic renal disease. Semin Nephrol 29:144\u2013155","journal-title":"Semin Nephrol"},{"key":"3861_CR21","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/j.ajkd.2010.02.338","volume":"55","author":"PL Gordon","year":"2010","unstructured":"Gordon PL, Frassetto LA (2010) Management of osteoporosis in CKD stages 3 to 5. Am J Kidney Dis: Off J Natl Kidney Found 55:941\u2013956","journal-title":"Am J Kidney Dis: Off J Natl Kidney Found"},{"issue":"Suppl 1","key":"3861_CR22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1755-6686.2009.00067.x","volume":"35","author":"F Svara","year":"2009","unstructured":"Svara F (2009) Chronic kidney disease-mineral and bone disorder (CKD-MBD): a new term for a complex approach. J Renal Care 35(Suppl 1):3\u20136","journal-title":"J Renal Care"},{"key":"3861_CR23","unstructured":"(2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney international Supplement S1\u2013130"},{"key":"3861_CR24","doi-asserted-by":"crossref","first-page":"970245","DOI":"10.4061\/2011\/970245","volume":"2011","author":"M Ketteler","year":"2011","unstructured":"Ketteler M (2011) Phosphate metabolism in CKD stages 3-5: dietary and pharmacological control. Int J Nephrol 2011:970245","journal-title":"Int J Nephrol"},{"key":"3861_CR25","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2215\/CJN.04040411","volume":"7","author":"ML Melamed","year":"2012","unstructured":"Melamed ML, Thadhani RI (2012) Vitamin D therapy in chronic kidney disease and end stage renal disease. Clin J Am Soc Nephrol: CJASN 7:358\u2013365","journal-title":"Clin J Am Soc Nephrol: CJASN"},{"key":"3861_CR26","first-page":"210","volume":"6","author":"P Bolasco","year":"2009","unstructured":"Bolasco P (2009) Treatment options of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease stages 3 and 4: an historic review. Clin Cases Miner Bone Metab : Off J Ital Soc Osteoporos, Miner Metabol, Skelet Dis 6:210\u2013219","journal-title":"Clin Cases Miner Bone Metab : Off J Ital Soc Osteoporos, Miner Metabol, Skelet Dis"},{"key":"3861_CR27","doi-asserted-by":"crossref","first-page":"14044","DOI":"10.1038\/boneres.2014.44","volume":"2","author":"PD Miller","year":"2014","unstructured":"Miller PD (2014) Chronic kidney disease and the skeleton. Bone Res 2:14044","journal-title":"Bone Res"},{"key":"3861_CR28","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1056\/NEJMct1004903","volume":"363","author":"MJ Favus","year":"2010","unstructured":"Favus MJ (2010) Bisphosphonates for osteoporosis. N Engl J Med 363:2027\u20132035","journal-title":"N Engl J Med"},{"key":"3861_CR29","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1359\/JBMR.050817","volume":"20","author":"PD Miller","year":"2005","unstructured":"Miller PD, Roux C, Boonen S, Barton IP, Dunlap LE, Burgio DE (2005) Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and gault method: a pooled analysis of nine clinical trials. J Bone Miner Res : Off J Am Soc Bone Miner Res 20:2105\u20132115","journal-title":"J Bone Miner Res : Off J Am Soc Bone Miner Res"},{"key":"3861_CR30","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1359\/jbmr.070112","volume":"22","author":"SA Jamal","year":"2007","unstructured":"Jamal SA, Bauer DC, Ensrud KE, Cauley JA, Hochberg M, Ishani A, Cummings SR (2007) Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial. J Bone Miner Res : Off J Am Soc Bone Miner Res 22:503\u2013508","journal-title":"J Bone Miner Res : Off J Am Soc Bone Miner Res"},{"key":"3861_CR31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00198-006-0189-8","volume":"18","author":"PD Miller","year":"2007","unstructured":"Miller PD, Schwartz EN, Chen P, Misurski DA, Krege JH (2007) Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment. Osteoporos Int : J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA 18:59\u201368","journal-title":"Osteoporos Int : J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"3861_CR32","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00223-010-9414-8","volume":"87","author":"M Sridharan","year":"2010","unstructured":"Sridharan M, Cheung J, Moore AE, Frost ML, Fraser WD, Fogelman I, Hampson G (2010) Circulating fibroblast growth factor-23 increases following intermittent parathyroid hormone (1-34) in postmenopausal osteoporosis: association with biomarker of bone formation. Calcif Tissue Int 87:398\u2013405","journal-title":"Calcif Tissue Int"},{"key":"3861_CR33","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1210\/en.2009-0472","volume":"150","author":"R Samadfam","year":"2009","unstructured":"Samadfam R, Richard C, Nguyen-Yamamoto L, Bolivar I, Goltzman D (2009) Bone formation regulates circulating concentrations of fibroblast growth factor 23. Endocrinology 150:4835\u20134845","journal-title":"Endocrinology"},{"key":"3861_CR34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000151727","volume":"189","author":"Y Lu","year":"2009","unstructured":"Lu Y, Qin C, Xie Y, Bonewald LF, Feng JQ (2009) Studies of the DMP1 57-kDa functional domain both in vivo and in vitro. Cells Tissues Organs 189:175\u2013185","journal-title":"Cells Tissues Organs"},{"key":"3861_CR35","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/ndt\/gfh876","volume":"20","author":"Y Iwasaki-Ishizuka","year":"2005","unstructured":"Iwasaki-Ishizuka Y, Yamato H, Nii-Kono T, Kurokawa K, Fukagawa M (2005) Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone. Nephrol, Dial, Transplant : Off Publ Eur Dial Transplant Assoc \u2013 Eur Renal Assoc 20:1904\u20131911","journal-title":"Nephrol, Dial, Transplant : Off Publ Eur Dial Transplant Assoc \u2013 Eur Renal Assoc"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3861-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-016-3861-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3861-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T01:28:51Z","timestamp":1498354131000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-016-3861-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,8]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["3861"],"URL":"https:\/\/doi.org\/10.1007\/s00198-016-3861-7","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,8]]}}}